{"originalText": "缘于入院前3个月月于我院诊为“卵巢癌”，于2013-10-16在我科行“全麻上行盆腔粘连松解+阔韧带肿物切除术+全子宫切除术”，术后病理回报示：卵巢子宫内膜样腺癌I级，术后恢复良好，伤口愈合II/甲。术后于2013-11-03及2013-11-27予“多西他赛70MG/M2IVGTTD1+洛铂30MG/M2IVGTTD1”方案化疗2次，化疗过程顺利，第2次化疗出现II度骨髓抑制,予升白治疗后好转出院。2013-12-26予“紫杉醇240MGIVGTTD1+洛铂50MGIVGTTD1”方案第3次化疗，化疗过程顺利，化疗后出现II度骨髓抑制,予升白治疗后好转出院。现化疗间期已满，患者无畏冷、发热，无恶心、呕吐，无腹痛、腹泻等不适，今为求进一步诊治，门诊拟“卵巢子宫内膜样腺癌(II期，I级)术后”收入院。下次出院以来，精神、睡眠、饮食可，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 36, "end_pos": 62}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 72, "end_pos": 83}, {"end_pos": 130, "label_type": "药物", "overlap": 0, "start_pos": 126}, {"end_pos": 147, "label_type": "药物", "overlap": 0, "start_pos": 145}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 183, "end_pos": 190}, {"end_pos": 217, "label_type": "药物", "overlap": 0, "start_pos": 214}, {"end_pos": 232, "label_type": "药物", "overlap": 0, "start_pos": 230}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 264, "end_pos": 271}, {"end_pos": 309, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 312, "label_type": "解剖部位", "overlap": 0, "start_pos": 311}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 330, "end_pos": 349}]}
